Unichem Laboratories Ltd reported a significant improvement in profitability for the quarter ended March 31, 2025 (Q4 FY25). The company posted a consolidated net profit of ₹52.97 crore, compared to a loss of ₹136.74 crore in the same quarter last year.
Total income for the quarter stood at ₹596.43 crore, rising from ₹465.75 crore a year earlier. Revenue from operations came in at ₹587.18 crore, up 27.9% year-on-year (YoY), driven by strong operational performance.
A notable highlight for the quarter was the sharp jump in EBITDA, which rose to ₹83.7 crore from ₹21.6 crore in Q4 FY24, marking a nearly fourfold increase. As a result, the EBITDA margin expanded to 14.25%, up from 4.71% YoY.
On an annual basis, Unichem reported FY25 revenue of ₹2,146.29 crore, up from ₹1,816.70 crore in FY24. The company turned profitable with a full-year PAT of ₹137.52 crore in FY25 versus a loss of ₹93.76 crore in the previous year.
Cost control measures, improved gross margins, and a reduction in inventory-related drag contributed to the turnaround. Total expenses for Q4 FY25 stood at ₹538.63 crore, compared to ₹473.44 crore a year ago.
The management’s operational focus and financial discipline have played a key role in reviving the company’s profitability.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
